TransMedics Group, Inc. (TMDX)
| Market Cap | 2.38B |
| Revenue (ttm) | 441.54M |
| Net Income (ttm) | 35.46M |
| Shares Out | 33.66M |
| EPS (ttm) | 1.01 |
| PE Ratio | 70.09 |
| Forward PE | 47.05 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 367,743 |
| Open | 71.99 |
| Previous Close | 71.47 |
| Day's Range | 69.62 - 72.11 |
| 52-Week Range | 55.00 - 177.37 |
| Beta | 2.12 |
| Analysts | Buy |
| Price Target | 118.44 (+67.19%) |
| Earnings Date | Apr 29, 2025 |
About TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung trans... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for TMDX stock is "Buy." The 12-month stock price forecast is $118.44, which is an increase of 67.19% from the latest price.
News
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses – Hagens Berman
SAN FRANCISCO, March 24, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant th...
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
SAN FRANCISCO, March 21, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant th...
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses– Hagens Berman
TMDX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / March 20, 2025 / A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ:TMDX), a ...
TransMedics: A Very Bullish Last Few Months Could Change Sentiment
TransMedics Group, Inc. shows strong Q4 results with revenue at $121.6m and EPS at $0.2, beating estimates and reassuring investors. TMDX's long-term growth potential is supported by its innovative or...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In TransMedics To Contact Him Directly To Discuss Their Options
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses - Hagens Berman
TMDX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / March 14, 2025 / A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ:TMDX), a ...
Here Are 5 Companies I'd Aggressively Add To Amid Rising Market Volatility
Despite recent market volatility, now is the time to be aggressive in investing, focusing on companies with strong fundamentals and growth potential. Nu Holdings, despite macroeconomic challenges, off...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options
TransMedics: Aggressive Guidance Largely Ignored By The Market
TransMedics' stock has rebounded modestly in recent months on the back of a strong fourth quarter performance. Continued market growth and TransMedics return to gaining market share should help to boo...
Investors Who Purchased Shares of TransMedics Group, Inc. (NASDAQ: TMDX) Should Contact the Shareholders Foundation in Connection With Lawsuit
A lawsuit was filed for certain investors in TransMedics Group, Inc. (NASDAQ: TMDX) shares. Investors who purchased shares of TransMedics Group, Inc. (NASDAQ: TMDX) prior to February 2023 and continue...
TMDX REMINDER: TransMedics Group, Inc. was Sued for Securities Fraud; Investors are Alerted to Contact BFA Law before April 15 Deadline (NASDAQ:TMDX)
NEW YORK, March 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) and certain o...
Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. Investors with Losses to Contact the Firm
RADNOR, Pa. , March 1, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against TransMedi...
TransMedics Group, Inc. (TMDX) Q4 2024 Earnings Call Transcript
TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group, Investor Relations Waleed Hassanein - Presiden...
TransMedics Reports Fourth Quarter and Full Year 2024 Financial Results
ANDOVER, Mass. , Feb. 27, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-...
TransMedics: Data Points To A Miss On Low Expectations, Followed By Big Improvement
TransMedics is expected to report disappointing Q4 results, with industry data suggesting it will likely miss and come in at the low end of guidance. The company's Q3 performance was poor, underperfor...
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking - Hagens Berman
SAN FRANCISCO, CA / ACCESS Newswire / February 25, 2025 / A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ:TMDX), a medical technology company specializing in organ transp...
TMDX REMINDER: Kessler Topaz Meltzer & Check, LLP Urges TMDX Investors with Losses to Contact the Firm
RADNOR, Pa., Feb. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United S...
TransMedics: Big Growth And Operational Advantages, Buy This Leading Medical Player
TransMedics Group is revolutionizing organ transplant therapy with its FDA-approved Organ Care System, enhancing donor organ preservation and transport. Despite a Q3 earnings miss and short-seller all...
TMDX SECURITIES NEWS: TransMedics Group has been Sued for Securities Fraud - Investors are Alerted to Contact BFA Law by April 15 Legal Deadline (NASDAQ:TMDX)
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ:TMDX) and ce...
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman
SAN FRANCISCO , Feb. 21, 2025 /PRNewswire/ -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant therap...
TransMedics to Present at Upcoming March Investor Conferences
ANDOVER, Mass. , Feb. 18, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-...
Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities Laws
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NAS...
TMDX STOCK REPORT: Suffer Losses on TransMedics Group, Inc.? Contact BFA Law about its Investigation into the Company
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ:TMDX) for potential violatio...